Fig 5. Expression of CD34+ cells in NSF skin as shown by immunohistochemistry.
Panel A shows (as indicated by arrows) more CD34+ cells in CKD skin of Omniscan-injected mice. This was significant statistically (***p<0.001, Panel B). Quantitative analysis shows that CD34 was not reduced significantly with deferiprone treatment (Panel B).